周鑫，北京大学医学部外科学专业博士，副主任医师、副研究员、硕士生导师。2011-2016 北京大学医学部 博士；2016-2017 北京大学第三医院普通外科 住院医师；2017-2022 北京大学第三医院普通外科 主治医师；2021-至今 北京大学第三医院普通外科 副研究员；2022-至今 北京大学第三医院普通外科 副主任医师。擅长胃肿瘤、胃癌、胃印戒细胞癌、胃淋巴瘤、胃良性肿瘤、肠道肿瘤、直肠癌、结肠癌、大肠癌、肛乳头瘤、乙状结肠癌、十二指肠癌。
Xin ZHOU holds a PhD in Surgery from Peking University Health Science Center (PUHSC). He currently serves as Associate Chief Physician, Associate Research Fellow, and Master's Supervisor at PKUH3. His academic and professional journey includes: 2011–2016, pursuing a PhD at PUHSC; 2016–2017, working as a Resident Physician in the Department of General Surgery, PKUH3; 2017–2022, serving as an Attending Physician in the same department; 2021–present, holding the position of Associate Research Fellow in the same department; and 2022–present, acting as Associate Chief Physician in the same department. His clinical expertise covers gastric tumors, gastric cancer, gastric signet ring cell carcinoma, gastric lymphoma, benign gastric tumors, intestinal tumors, rectal cancer, colon cancer, colorectal cancer, anal papilloma, sigmoid colon cancer, and duodenal cancer.
周鑫，博士毕业于北京大学医学部，2016-2017在北京大学第三医院普通外科任住院医师，2017-2022在北京大学第三医院普通外科任主治医师，2021-至今在北京大学第三医院普通外科任副研究员，2022-至今在北京大学第三医院普通外科任副主任医师。临床擅长胃肠肿瘤的微创治疗和多学科协作诊疗，阑尾肿瘤、肠梗阻的诊断及治疗。基于在临床实践中发现的科学问题，积极开展“以临床问题为导向”的转化医学研究，主持国家级、省部级等课题6项，在国际知名学术期刊包括Science、Cancer Cell、Gut上发表学术论文10余篇，参与奈特胃肠病学（第三版）的编译。获得北京市科技新星。
Xin ZHOU obtained his PhD from Peking University Health Science Center. He embarked on his clinical career at Peking University Third Hospital (PKUH3): from 2016 to 2017, he worked as a Resident Physician in the Department of General Surgery; from 2017 to 2022, he was promoted to Attending Physician in the same department. Since 2021, he has held the role of Associate Research Fellow in the Department of General Surgery, PKUH3, and in 2022, he further advanced to Associate Chief Physician in the same department. Clinically, Dr. ZHOU specializes in minimally invasive treatment of gastrointestinal tumors and multidisciplinary team (MDT) diagnosis and treatment. He also has extensive experience in the diagnosis and management of appendiceal tumors and intestinal obstruction. Driven by clinical challenges identified in practice, he proactively conducts "clinical problem-oriented" translational medicine research. To date, he has presided over 6 research projects at national and provincial levels. In terms of academic achievements, Dr. ZHOU has published more than 10 academic papers in internationally renowned journals, including Science, Cancer Cell, and Gut—all of which are highly influential in the global medical community. Additionally, he participated in the compilation and translation of Knight's Gastroenterology (3rd Edition), a classic textbook in the field of gastroenterology. His outstanding contributions to clinical practice and medical research have earned him the honor of "Beijing Science and Technology New Star," recognizing his potential and achievements in advancing medical science and clinical care.
周宇峰，男，哲学博士，教授，博士生导师。于1996和1999年获得南京大学学士和硕士学位；2003年获美国杜克大学博士学位；2003-2006年在杜克大学治疗研究实验室从事超声治疗的博士后研究；2006年任ImaRx Therapeutics Ltd超声工程师；2007-2010年任美国华盛顿大学研究科学家；2010-2020年任新加坡南洋理工大学助理教授，主持生物超声研究；2021年至今任重庆医科大学教授。出版专著《Optimization of pressure field in shock wave lithotripsy: pressure waveform, distribution and sequence》和《Principle and Application of Therapeutic Ultrasound》，发表SCI论文80余篇。
Yufeng ZHOU, male, holds a Doctor of Philosophy (PhD), and serves as a Professor and Doctoral Supervisor. He obtained his Bachelor's and Master's degrees from Nanjing University in 1996 and 1999 respectively, and his PhD from Duke University, USA in 2003. From 2003 to 2006, he conducted postdoctoral research on ultrasound therapy at the Therapeutic Research Laboratory of Duke University. In 2006, he worked as an Ultrasound Engineer at ImaRx Therapeutics Ltd. Between 2007 and 2010, he served as a Research Scientist at the University of Washington, USA. From 2010 to 2020, he was an Assistant Professor at Nanyang Technological University, Singapore, leading research in biomedical ultrasound. Since 2021, he has been a Professor at Chongqing Medical University. He has published two monographs, Optimization of pressure field in shock wave lithotripsy: pressure waveform, distribution and sequence and Principle and Application of Therapeutic Ultrasound, and over 80 SCI-indexed papers.
周宇峰，美国杜克大学博士学位，2003-2006年在杜克大学质量研究实验室从事超声治疗博士后研究；2007-2010年任美国华盛顿大学医学院、应用物理实验室工业与医学超声中心研究科学家；2010年在南洋理工大学任教，主持生物超声研究；2021年至今任重庆医科大学教授。IEEE（美国电气与电子工程师协会）高级会员，Ultrasound in Medicine & Biology建议委员会成员，2010-2020新加坡声学学会秘书长。研究方向：超声治疗生物学效应、声空化、声传播理论与测量、冲击波技术、微流道声泳等。出版专著《Optimization of pressure field in shock wave lithotripsy: pressure waveform, distribution and sequence》和《Principle and Application of Therapeutic Ultrasound》，发表SCI论文80余篇。
Yufeng ZHOU holds a PhD from Duke University, USA. From 2003 to 2006, he carried out postdoctoral research on ultrasound therapy at the Quality Research Laboratory of Duke University. Between 2007 and 2010, he served as a Research Scientist at the Center for Industrial and Medical Ultrasound, Applied Physics Laboratory, School of Medicine, University of Washington, USA. In 2010, he joined Nanyang Technological University as a faculty member, where he led research in biomedical ultrasound; his tenure at the university lasted until 2020. Since 2021, he has been a Professor at Chongqing Medical University. Academic Affiliations & Roles: Senior Member of the Institute of Electrical and Electronics Engineers (IEEE); Member of the Advisory Board of Ultrasound in Medicine & Biology; Secretary-General of the Acoustical Society of Singapore (2010–2020). Research Directions: Biological effects of therapeutic ultrasound; Acoustic cavitation; Acoustic propagation theory and measurement; Shock wave technology; Acoustophoresis in microchannels. Professor ZHOU has made substantial contributions to the field of biomedical ultrasound through his academic outputs. He is the author of two influential monographs: Optimization of pressure field in shock wave lithotripsy: pressure waveform, distribution and sequence (focused on optimizing pressure fields in shock wave lithotripsy) and Principle and Application of Therapeutic Ultrasound (systematically elaborating on the fundamentals and practical uses of therapeutic ultrasound). Additionally, he has published over 80 SCI-indexed papers, which have provided valuable insights for advancements in areas such as ultrasound therapy, acoustic cavitation, and shock wave technology, solidifying his academic influence in the international biomedical ultrasound community.
张练，中国科学技术大学博士，美国梅奥医院放疗科博士后，德国国家放射肿瘤中心博士后。在AI肿瘤临床诊疗研究，以及临床质子放疗、射波刀放疗等前沿放疗技术领域，均拥有丰富的科研与临床实践经验。曾参与科技部重点研发计划、美国NIH R01等重大课题。担任多个学术期刊编委及审稿人，并在多家专业学会任职，入选河北省“燕赵黄金台聚才计划”拔尖人才。
Dr. Zhang Lian earned his Ph.D. from the University of Science and Technology of China (USTC). He conducted postdoctoral research at the Department of Radiation Oncology, Mayo Clinic (USA), followed by a research fellowship at the German National Center for Radiation Oncology. He has extensive expertise in both the translational research of artificial intelligence for clinical oncology and the application of advanced radiotherapy techniques, including clinical proton therapy and CyberKnife radiotherapy. Dr. Zhang has contributed to several major research initiatives, including the National Key R&D Program of China, the U.S. NIH R01 project, and the EU Horizon 2020 program. He has also authored numerous SCI-indexed papers. He has been honored with the "Top Talent" award from the Hebei Province "Yanzhao Golden Terrace" Talent Gathering Program. Dr. Zhang actively serves in multiple editorial and peer-review capacities and is a member of several prestigious professional academic committees.
现任河北医科大学第一医院 医学人工智能实验室主任、数据管理处副处长、放射治疗中心副主任、肿瘤学科科研副主任、肿瘤医疗决策AI大模型河北省工程研究中心主任；曾参与科技部重点研发计划、美国国立卫生研究院NIH R01课题、欧盟地平线Horizon 2020重大专项课题；对人工智能技术在肿瘤临床诊疗中的研究与转化有较为丰富研究经验，在临床质子放疗、射波刀放疗等前沿放疗技术有较为丰富临床经验，发表SCI论文多篇；河北省燕赵黄金台聚才计划拔尖人才、美国医学物理协会AAPM委员、河北省数理医学学会多模态医学大模型创新应用专业委员会主委、中国研究型医院学会临床数据与样本资源库专委会委员、中国抗癌协会肿瘤信息化管理专委会委员，中国抗癌协会整合肿瘤相关结节专业委员会委员、河北省临床医学工程学会放疗物理技术工程分会委员；Journal of Applied Clinical Medical Physics副主编、《Meta-Radiology》青年编委、《Intelligent Oncology》青年编委、《河北医科大学学报》编委、《河北医药》青年编委，红皮杂志 IJRO、绿皮杂志R&O、Medical Physics、IEEE Journal、ARO等期刊特约审稿人。
Current Hospital Leadership:Director of Medical AI Lab;Deputy Director of Data Center;Research Director of Oncology;Deputy Director of Radiation Therapy Center;Director of the Hebei Provincial Engineering Research Center for AI Large Models in Tumor Medical Decision-Making
Professional Affiliations:
Awardee of "Top Talent" Title, Hebei Province Yanzhao Golden Terrace Talent Gathering Program
Member, American Association of Physicists in Medicine (AAPM)
Chairperson, Multimodal Medical Large Model Innovation and Application Committee, Hebei Society of Mathematical Medicine
Member, Clinical Data and Sample Biobank Committee, Chinese Research Hospital Association
Member, Oncology Informatization Management Committee, Chinese Anti-Cancer Association
Member, Integrated Tumor-Related Nodules Committee, Chinese Anti-Cancer Association
Member, Radiotherapy Physics and Technology Engineering Society, Hebei Clinical Engineering Association
Editorial and Peer-Review Roles:
Associate Editor, Journal of Applied Clinical Medical Physics
Youth Editorial Board Member, Meta-Radiology
Youth Editorial Board Member, Intelligent Oncology
Editorial Board Member, Journal of Hebei Medical University
Youth Editorial Board Member, Hebei Medical Journal
Ad-hoc Reviewer for renowned journals including the International Journal of Radiation Oncology, Biology, Physics (IJROBP, "Red Journal"), Radiotherapy and Oncology (R&O, "Green Journal"), Medical Physics, IEEE Journal, and ARO.
